FDA Expands Leucovorin Use, Clarifies Position on Autism Claims

In Brief

The FDA has broadened leucovorin's approved uses but has withdrawn previous autism-related claims.

Key Facts

• The FDA expanded the approved use of the drug leucovorin.
• The agency has retracted earlier claims about leucovorin's effectiveness for autism.
• U.S. doctors continue prescribing leucovorin despite unresolved questions about the drug.

What Happened

The FDA has expanded leucovorin's approved uses while walking back previous claims regarding its effectiveness for autism, according to The Independent.

Why It Matters

The FDA's decision may affect prescribing practices and patient expectations regarding leucovorin, especially concerning autism-related uses. Ongoing prescriptions despite unresolved questions highlight the need for further clarity. Based on a single source report

What's Next

Further research or regulatory updates may clarify leucovorin's uses and effectiveness. Medical professionals and patients may look for additional guidance from health authorities.